Filing Flows › Paysign (PAYS) › How it makes money
How Paysign (PAYS) makes money
Paysign (PAYS) made $28.3M of revenue in the second quarter 2026 (Q2 2026), +48% from a year earlier. Pharma Industry brought in $14.6M (52%); Plasma Industry brought in $13.0M (46%); Other Revenue brought in $562K (2%). Of every dollar of revenue, 63¢ was left as gross profit, 25¢ was left as operating profit, 24¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q2 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Pharma Industry | $14.6M | 51.7% | -7% | +89% |
| Plasma Industry | $13.0M | 46.0% | +11% | +21% |
| Other Revenue | $562K | 2.0% | -8% | -3% |
| Breakage Revenue | $76K | 0.3% | -32% | +38% |
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $28.3M | 100.0% |
| Cost of revenue | $10.4M | 36.6% |
| Gross profit | $17.9M | 63.2% |
| Operating expenses | $10.9M | 38.4% |
| Operating profit | $7.0M | 24.7% |
| Income tax | $1.1M | 4.1% |
| Net earnings | $6.8M | 23.9% |
| Operating cash flow | $1.3M | 4.6% |
| Free cash flow | $1.2M | 4.2% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $28.3M | +48% |
| Q1 2026 | $28.0M | +51% |
| Q4 2025 | $22.8M | +46% |
| Q3 2025 | $21.6M | +42% |
| Q2 2025 | $19.1M | +33% |
| Q1 2025 | $18.6M | +41% |
| Q4 2024 | $15.6M | +14% |
From Paysign's 10-Q filed Aug 6, 2026 (on EDGAR).
Questions
How does Paysign make money?
Paysign (PAYS) made $28.3M of revenue in the second quarter 2026 (Q2 2026), +48% from a year earlier. Pharma Industry brought in $14.6M (52%); Plasma Industry brought in $13.0M (46%); Other Revenue brought in $562K (2%). Of every dollar of revenue, 63¢ was left as gross profit, 25¢ was left as operating profit, 24¢ was left as net earnings.
What is Paysign's biggest business?
Pharma Industry: $14.6M in the second quarter 2026, 52% of revenue, +89% from a year earlier.
What is Paysign's profit margin?
Net earnings were $6.8M, 23.9% of revenue, in the second quarter 2026; the operating margin was 24.7%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.